To evaluate the efficacy of a lactobacilli preparation on Bacterial vaginosis, HIV infectivity and vaginal immunity in healthy subjects and subjects with bacterial vaginosis

CD Pharma India Pvt Ltd0 个研究点目标入组 140 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Healthy women of reproductive age group over 18 years
•Bacterial vaginosis to be excluded by Nugent score (healthy patients)
•b.Bacterial vaginosis diagnosis is based on the Nugent method (in patients with bacterial vaginosis)
•Exclusion of any other vaginal infection by standard diagnostic procedure.
•Written informed consent

•Post menopausal women
•Pregnant women
•Abnormal uterine bleeding (not including cervical contact bleeding on sampling) or vaginal bleeding of unknown origin.
•AIDS patients or patients with any kind of cancer or tumor
•Diabetes mellitus
•Drug addiction
•Antibiotic use (local or systemic) in the previous 20 days.
•Use of any vaginal medication in the previous 7 days.
•Participation in any other study 30 days before beginning of the present study.
•Known or suspected hypersensitivity to any of the ingredients of the trial medication.
•No informed consent.
•Patient not willing to comply with the trial instructions.

发起方